UCB
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.cimziahcp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About UCB
UCB, Inc. offers CIMZIA, a tumor necrosis factor (TNF) blocker designed for the treatment of various immunological conditions, including moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease. With more than 15 years of clinical history, their products aim to address the individualized needs of patients experiencing these conditions. The company also provides patient support resources through CIMplicity, enhancing patient experience and adherence. Their primary clientele includes healthcare professionals and patients seeking advanced therapeutic options for complex immunological disorders.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is UCB your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at UCB
Product Launch: Get notified when UCB launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if UCB had a recent Job posting/layoffs
Check out if UCB is spiking on competitors!
UCB, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once UCB has new funding data
Check if UCB has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on UCB recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to UCB
Compare insights from companies similar to UCB, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
UCB
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
UCB is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
UCB is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about UCB.
UCB Tech Stack
A closer look at the technologies used by UCB
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UCB
Sign Up For FreeTo access detailed company insights
UCB, Inc. offers CIMZIA, a tumor necrosis factor (TNF) blocker designed for the treatment of various immunological conditions, including moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease. With more than 15 years of clinical history, their products aim to address the individualized needs of pat... Read More
